177 related articles for article (PubMed ID: 9731955)
1. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Cheng Z; McKeller Q; Nolan A
J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
Arifah AK; Lees P
J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
[TBL] [Abstract][Full Text] [Related]
3. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
Cheng Z; Nolan AM; McKellar QA
Inflammation; 1998 Aug; 22(4):353-66. PubMed ID: 9675607
[TBL] [Abstract][Full Text] [Related]
4. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
Lees P; Taylor JB; Higgins AJ; Sharma SC
J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Foreman JH; Ruemmler R
Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Landoni MF; Lees P
Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
Aliabadi FS; Lees P
J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
[TBL] [Abstract][Full Text] [Related]
9. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
10. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
Scherkl R; Hashem A; Frey HH
Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
[TBL] [Abstract][Full Text] [Related]
12. Disposition and tolerance of suxibuzone in horses.
Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of flunixin meglumine in the sheep.
Welsh EM; McKellar QA; Nolan AM
J Vet Pharmacol Ther; 1993 Jun; 16(2):181-8. PubMed ID: 8345568
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
Toutain PL; Autefage A; Legrand C; Alvinerie M
J Vet Pharmacol Ther; 1994 Dec; 17(6):459-69. PubMed ID: 7707492
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
[TBL] [Abstract][Full Text] [Related]
18. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
Pellegrini-Masini A; Poppenga RH; Sweeney RW
J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
[TBL] [Abstract][Full Text] [Related]
19. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
Kopcha M; Ahl AS
J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of flunixin and its effect on prostaglandin F2 alpha metabolite concentrations after oral and intravenous administration in heifers.
Odensvik K
J Vet Pharmacol Ther; 1995 Aug; 18(4):254-9. PubMed ID: 8583538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
